Keeping momentum going, Oura announced a new ceramic smart ring lineup today, along with multi-ring support in the app, as ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...

The San Diego-based company claims a number of firsts for its coin-sized Biolinq Shine device, including that it is so far ...

In-depth Oura Ring 4 review vs Oura Ring 3. Tested sleep, activity, stress & readiness tracking. What’s new in 2025 – and is ...

It's been a year of change at Intuitive Surgical, but the leader in surgical robotics continues to push forward with ...

The FDA has granted de novo classification to the Biolinq Shine wearable biosensor, which would be the first needle-free CGM ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and ...